|
Issue |
Title |
|
No 16 (2019) |
First experience of using valsartan/sacubitril in women with heart failure and breast cancer receiving anthracycline-based adjuvant chemotherapy |
Abstract
PDF (Rus)
|
S. G. Kanorskiy, V. P. Pavlovets |
|
No 16 (2019) |
Chronic heart failure: actual aspects of treatment in real clinical practice |
Abstract
PDF (Rus)
|
D. I. Trukhan, E. L. Davydov |
|
No 16 (2018) |
Heart failure and senile asthenia syndrome |
Abstract
PDF (Rus)
|
Yu. V. Kotovskaya, A. V. Rozanov, D. H. Kurashev, O. N. Tkacheva |
|
No 16 (2018) |
Myocarditis as a cause of chronic heart failure |
Abstract
PDF (Rus)
|
E. V. Filippov |
|
No 5 (2018) |
Influence of therapy with trimetazidine on the state of the main vessels and microcirculation in patients with CHF and DM type 2. The results of the original study |
Abstract
PDF (Rus)
|
M. E. Statsenko, S. V. Fabritskaya, U. A. Ryndina |
|
No 5 (2018) |
Mineralocorticoid receptor antagonists: new extended roles in cardio- and nephroprotection |
Abstract
PDF (Rus)
|
A. M. Esayan, A. N. Nimgirova |
|
No 7 (2017) |
CLINICAL VALUE OF DETERMINING GALECTIN-3 IN PATIENTS WITH CHRONIC HEART FAILURE |
Abstract
PDF (Rus)
|
K. A. Gyamdzhyan, V. G. Kukes, M. L. Maksimov |
|
No 7 (2017) |
NEW PROSPECTS IN PHARMACOLOGICAL TREATMENT OF ACUTE DECOMPENSATED HEART FAILURE. EXPERIENCE WITH SERELAXIN. A CLINICAL CASE |
Abstract
PDF (Rus)
|
S. D. Mayanskaya |
|
No 7 (2017) |
MYOCARDIAL CYTOPROTECTOR TRIMETAZIDINE MB-PREPARAT, INCREASES THE EFFECTIVENESS OF TREATMENT OF CHRONIC HEART FAILURE AND CORONARY HEART DISEASE |
Abstract
PDF (Rus)
|
D. I. Trukhan, A. L. Mazurov, E. L. Davydov |
|
No 12 (2017) |
INNOVATIVE STRATEGY IN THERAPY OF CARDIAC INSUFFICIENCY |
Abstract
PDF (Rus)
|
N. A. Jaiani |
|
No 12 (2017) |
EFFECTIVENESS OF MELDONIUMIN IN CHRONIC HEART FAILURE PATIENTS |
Abstract
PDF (Rus)
|
G. N. Gorokhovskaya, V. L. Yoon, A. S. Skotnikov, A. I. Martynov, E. Yu. Maychuk |
|
No 12 (2017) |
РЕЗУЛЬТАТЫ ИССЛЕДОВАНИЯ TOPCAT: ДОСТИЖИМА ЛИ АБСОЛЮТНАЯ ОБЪЕКТИВНОСТЬ? |
Abstract
PDF (Rus)
|
|
|
No 13 (2016) |
THERAPEUTIC EFFECT ON HEART RATE: VISIBLE SIMPLICITY AND REAL DIFFICULTY |
Abstract
PDF (Rus)
|
S. R. GILYAREVSKY, M. V. GOLSHMID, I. M. KUZMINA |
|
No 13 (2016) |
TORASEMIDE SAFETY IN COMPLEX THERAPY OF CHRONIC CARDIAC INSUFFICIENCY: RESULTS OF RANDOMIZED CROSS STUDY |
Abstract
PDF (Rus)
|
E. E. AVERIN |
|
No 12 (2014) |
Selection of an ACE inhibitor in clinical practice |
Abstract
PDF (Rus)
|
OD Ostroumova, ML Maksimov, OV Dralova, AS Yermolayeva |
|
No 12 (2014) |
Clinical application of mineralocorticoid receptor antagonists in chronic heart failure |
Abstract
PDF (Rus)
|
MG Bubnova |
|
No 12 (2014) |
Effect of long-term therapy with AT1angiotensin II receptor blockers in combination with aldosterone receptor inhibitor on ischemic myocardial remodelling and chronic heart failure |
Abstract
PDF (Rus)
|
AT Teplyakov, EV Grakova, AV Andrianova, EY Pushnikova, NV Protopopova, RS Karpov |
|
No 9 (2013) |
Why reduce heart rate in patients with chronic heart failure? |
Abstract
PDF (Rus)
|
N. B. Perepech |
|
No 9 (2013) |
Renin-angiotensin system blockers: therapy of choice in patients with arterial hypertension and heart failure |
Abstract
PDF (Rus)
|
G. N. Gorokhovskaya, R. I. Shaburov, V. L. Yun |
|
No 9 (2013) |
Myocardial protection during myocardial revascularization: Preductal®MR |
Abstract
PDF (Rus)
|
Editorial Article |
|
1 - 20 of 20 Items |
|